Literature DB >> 22307088

Akt-dependent Skp2 mRNA translation is required for exiting contact inhibition, oncogenesis, and adipogenesis.

Veronique Nogueira1, Deepa Sundararajan, Jennifer M Kwan, Xiao-ding Peng, Neha Sarvepalli, Nahum Sonenberg, Nissim Hay.   

Abstract

The requirement of Akt for cell proliferation and oncogenesis is mammalian target of rapamycin complex 1 (mTORC1) dependent. SV40 large T expression in Akt-deficient cells restores cell proliferation rate, but is insufficient for exiting contact inhibition and oncogene-induced anchorage-independent growth, because of a failure to promote Skp2 mRNA translation. Skp2 mRNA and protein are induced upon exiting contact inhibition, which enables entry into mitosis. While Skp2 mRNA is induced in Akt-deficient cells, it is not translated, preventing entry into mitosis. Restoring Skp2 expression in Akt-deficient cells is sufficient to restore exit from contact inhibition and oncogenesis. Skp2 mRNA translation is dependent on mTORC1 and the eukaryotic translation initiation factor 4E (eIF4E). Thus, the requirement of Akt for exiting contact inhibition is mediated by the induction of Skp2 mRNA translation in eIF4E-dependent mechanism. These results provide a new insight into the role of the Akt/mTORC1/eIF4E axis in tumourigenesis. Akt-dependent Skp2 mRNA translation is also required for mitotic clonal expansion (MCE)--the earliest event in adipogenesis. Skp2 re-expression in Akt-deficient preadipocytes, which are impaired in adipogenesis, is sufficient to restore adipogenesis. These results uncover the mechanism by which Akt mediates adipogenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22307088      PMCID: PMC3297989          DOI: 10.1038/emboj.2011.478

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  44 in total

Review 1.  Adipocyte differentiation from the inside out.

Authors:  Evan D Rosen; Ormond A MacDougald
Journal:  Nat Rev Mol Cell Biol       Date:  2006-12       Impact factor: 94.444

2.  Hormonal induction of adipogenesis induces Skp2 expression through PI3K and MAPK pathways.

Authors:  Corinth A Auld; Carla D Caccia; Ron F Morrison
Journal:  J Cell Biochem       Date:  2007-01-01       Impact factor: 4.429

3.  Skp2-mediated p27(Kip1) degradation during S/G2 phase progression of adipocyte hyperplasia.

Authors:  Corinth A Auld; Karishma M Fernandes; Ron F Morrison
Journal:  J Cell Physiol       Date:  2007-04       Impact factor: 6.384

4.  Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2.

Authors:  Olivier Le Bacquer; Emmanuel Petroulakis; Sabina Paglialunga; Francis Poulin; Denis Richard; Katherine Cianflone; Nahum Sonenberg
Journal:  J Clin Invest       Date:  2007-02       Impact factor: 14.808

5.  Akt deficiency impairs normal cell proliferation and suppresses oncogenesis in a p53-independent and mTORC1-dependent manner.

Authors:  Jennifer E Skeen; Prashanth T Bhaskar; Chia-Chen Chen; William S Chen; Xiao-ding Peng; Veronique Nogueira; Annett Hahn-Windgassen; Hiroaki Kiyokawa; Nissim Hay
Journal:  Cancer Cell       Date:  2006-10       Impact factor: 31.743

6.  S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth.

Authors:  N Valerio Dorrello; Angelo Peschiaroli; Daniele Guardavaccaro; Nancy H Colburn; Nicholas E Sherman; Michele Pagano
Journal:  Science       Date:  2006-10-20       Impact factor: 47.728

Review 7.  Regulation of the cell cycle by SCF-type ubiquitin ligases.

Authors:  Keiichi I Nakayama; Keiko Nakayama
Journal:  Semin Cell Dev Biol       Date:  2005-06       Impact factor: 7.727

8.  Regulation of peroxisome proliferator-activated receptor gamma expression by adipocyte differentiation and determination factor 1/sterol regulatory element binding protein 1: implications for adipocyte differentiation and metabolism.

Authors:  L Fajas; K Schoonjans; L Gelman; J B Kim; J Najib; G Martin; J C Fruchart; M Briggs; B M Spiegelman; J Auwerx
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

9.  Skp2 controls adipocyte proliferation during the development of obesity.

Authors:  Tamon Sakai; Hiroshi Sakaue; Takehiro Nakamura; Mitsuru Okada; Yasushi Matsuki; Eijiro Watanabe; Ryuji Hiramatsu; Keiko Nakayama; Keiichi I Nakayama; Masato Kasuga
Journal:  J Biol Chem       Date:  2006-11-02       Impact factor: 5.157

10.  Loss of cyclin-dependent kinase inhibitors produces adipocyte hyperplasia and obesity.

Authors:  Afia Naaz; Denise R Holsberger; Gary A Iwamoto; Amanda Nelson; Hiroaki Kiyokawa; Paul S Cooke
Journal:  FASEB J       Date:  2004-10-06       Impact factor: 5.191

View more
  9 in total

1.  eIF4E is an adverse prognostic marker of melanoma patient survival by increasing melanoma cell invasion.

Authors:  Shahram Khosravi; Kevin J Tam; Gholamreza S Ardekani; Magdalena Martinka; Kevin J McElwee; Christopher J Ong
Journal:  J Invest Dermatol       Date:  2015-01-06       Impact factor: 8.551

2.  Skp2-dependent reactivation of AKT drives resistance to PI3K inhibitors.

Authors:  Emilie Clement; Hiroyuki Inuzuka; Naoe T Nihira; Wenyi Wei; Alex Toker
Journal:  Sci Signal       Date:  2018-03-13       Impact factor: 8.192

3.  Systemic Akt1 Deletion after Tumor Onset in p53(-/-) Mice Increases Lifespan and Regresses Thymic Lymphoma Emulating p53 Restoration.

Authors:  Wan-Ni Yu; Veronique Nogueira; Arya Sobhakumari; Krushna C Patra; Prashanth T Bhaskar; Nissim Hay
Journal:  Cell Rep       Date:  2015-07-16       Impact factor: 9.423

4.  Spontaneous Hepatocellular Carcinoma after the Combined Deletion of Akt Isoforms.

Authors:  Qi Wang; Wan-Ni Yu; Xinyu Chen; Xiao-Ding Peng; Sang-Min Jeon; Morris J Birnbaum; Grace Guzman; Nissim Hay
Journal:  Cancer Cell       Date:  2016-03-17       Impact factor: 31.743

5.  PI3K regulation of the SKP-2/p27 axis through mTORC2.

Authors:  K Shanmugasundaram; K Block; B K Nayak; C B Livi; M A Venkatachalam; S Sudarshan
Journal:  Oncogene       Date:  2012-06-25       Impact factor: 9.867

6.  HBV core promoter mutations and AKT upregulate S-phase kinase-associated protein 2 to promote postoperative hepatocellular carcinoma progression.

Authors:  Lubiao Chen; Lin Gu; Yurong Gu; Hongbo Wang; Meihai Deng; Zania Stamataki; Ye Htun Oo; Yuehua Huang
Journal:  Sci Rep       Date:  2016-10-25       Impact factor: 4.379

7.  Muscle transcriptome analysis identifies genes involved in ciliogenesis and the molecular cascade associated with intramuscular fat content in Large White heavy pigs.

Authors:  Martina Zappaterra; Silvia Gioiosa; Giovanni Chillemi; Paolo Zambonelli; Roberta Davoli
Journal:  PLoS One       Date:  2020-05-19       Impact factor: 3.240

8.  Inhibition of esophageal cancer growth through the suppression of PI3K/AKT/mTOR signaling pathway.

Authors:  Ni Shi; Hao Yu; Tong Chen
Journal:  Onco Targets Ther       Date:  2019-09-17       Impact factor: 4.147

Review 9.  Emerging Roles of SKP2 in Cancer Drug Resistance.

Authors:  Ting Wu; Xinsheng Gu; Hongmei Cui
Journal:  Cells       Date:  2021-05-10       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.